News & articles

Lexapro patent term extension decision now out

06 November 2014

Yesterday, the High Court of Australia issued a decision in the case of ALPHAPHARM PTY LTD v H LUNDBECK A/S & ORS. The High Court held that the Commissioner of Patents had the power to extend the time within which Lundbeck could apply for an extension of the term of its patent for the antidepressant drug escitalopram (sold as LEXAPRO).

Our people

David Simunic

Auckland, Senior Associate

David provides strategic advice on intellectual property portfolios including patents, designs, and copyright.

China Business Training

To help you prepare for doing business in China and succeed, NZTE has introduced China Business Training. Plan your path to exporting and get detailed information about doing business in China.

Learn more.

 

 

 

Get in touch

Our experts are here to help, whatever your intellectual property needs are.

Talk to us now

Twitter